| Literature DB >> 29899998 |
Kevin Yau1, Janine F Farragher1, S Joseph Kim1, Olusegun Famure1, Sarbjit V Jassal1.
Abstract
BACKGROUND: Functional disability is defined as the need for assistance with self-care tasks.Entities:
Keywords: elderly; functional dependence; geriatric; kidney transplant
Year: 2018 PMID: 29899998 PMCID: PMC5985553 DOI: 10.1177/2054358118775099
Source DB: PubMed Journal: Can J Kidney Health Dis ISSN: 2054-3581
Baseline and Follow-up Characteristics of Eligible Patients Who Participated in the Study Compared With Patients in the Original Cohort.
| Original cohort (n = 82) | Current study (n = 64) | ||||
|---|---|---|---|---|---|
| Baseline | Baseline | Follow-up | |||
| Demographics | |||||
| Age | 69.4 ± 4.2 | .91 | 69.4 ± 4.4 | 70.5 ± 4.4 | <.001 |
| Male gender | 45 (49%) | .72 | 37 (58%) | 37 (58%) | <.001 |
| Time with current transplant, years (median, IQR) | 4.7 (1.5, 10.7) | .98 | 5.0 (1.5, 9.1) | 6.2 (2.6, 10.3) | <.001 |
| Medications | |||||
| Number of hypertensive drugs | (n = 81) | .95 | 1.95 ± 1.08 | — | — |
| Prednisone use | 63 (77%) | .97 | 54 (84%) | 56 (88%) | .50 |
| Prednisone dose/6 months (mg) | (n = 81) | .99 | 840 ± 578 | 904 ± 503 | .44 |
| Laboratory data | |||||
| Hemoglobin (g/L) | 123.5 ± 19 | .68 | 122.2 ± 19 | 126.4 ± 19 | .03 |
| Serum albumin (g/L) | (n = 81) | .78 | 39.5 ± 3.6 | 39.9 ± 2.6 | .33 |
| Serum creatinine (µmol/L) | 134.6 ± 61 | .74 | 131.4 ± 58 | 140.6 ± 72 | .03 |
| Residence | |||||
| House | 45 (55%) | .98 | 35 (55%) | 31 (48%) | .42 |
| Apartment | 34 (42%) | .92 | 26 (41%) | 31 (48%) | .30 |
| Retirement residence | 3 (4%) | 1.00 | 3 (5%) | 2 (3%) | 1.00 |
| Lives alone | 11 (13%) | .91 | 9 (14%) | 13 (20%) | .22 |
| Employed | 15 (18%) | .76 | 13 (20%) | 10 (16%) | .38 |
| Comorbidities | |||||
| Number (median, IQR) | 3 (3, 5) | .87 | 3 (2, 5) | — | — |
| Diabetes | 41 (50%) | .71 | 35 (55%) | — | — |
| Ischemic heart disease | 21 (26%) | .90 | 17 (26 %) | — | — |
| Other cardiovascular disease[ | 76 (92%) | .65 | 58 (89%) | — | — |
| Neurological disease | 7 (9%) | .63 | 7 (11%) | — | — |
| Anticoagulation | 26 (32%) | .79 | 19 (30%) | — | — |
| Functional status | |||||
| TUG (seconds) | (n = 79) | .89 | (n = 62) | (n = 63) | .31 |
| Number of disabled ADLs | 1.7 ± 2.3 | .79 | 1.7 ± 2.4 | 1.9 ± 2.8 | .42 |
| Median number disabilities (range) | 1.00 (0-12) | — | 0.50 (0-12) | 0.50 (0-11) | — |
| TUG >10 seconds or not attempted | 51 (62%) | .97 | 40 (63%) | 33 (52%) | .04 |
| ≥1 ADL disability | 44 (54 %) | .95 | 32 (50%) | 32 (50%) | 1.00 |
| ≥1 reported fall in past year | 17 (21%) | .77 | 12 (19%) | 18 (28%) | .24 |
| Dominant handgrip <10th percentile | 24 (29%) | .96 | 25 (39%) | 29 (45%) | .42 |
Note. Plus-minus values are means ± SD. ADL = Activities of daily living; IQR = interquartile range; TUG = Timed Up and Go Test.
P value for differences at baseline between patients enrolled in the original cohort and those completing both baseline and follow-up study.
P value for differences between baseline and follow-up tests in those completing both baseline and follow-up assessments.
Other cardiovascular disease includes congestive heart failure, arrhythmias, hypertension, peripheral vascular disease, or other heart disease.
Figure 1.Stacked bar graph showing direction of functional change according to level of baseline disability.
Characteristics Showing Differences Within the Subgroup of Participants With Baseline Disability (n = 32) Comparing Those Who Demonstrated Further Functional Decline Over the Follow-up Period Versus Those Who Remained Stable or Improved.
| Progressive functional decline (n = 11) | Functional stability or improvement (n = 21) | |
|---|---|---|
| Age at follow-up | 72.0 ± 5.8 | 71.2 ± 4.6 |
| Male (%) | 8/11 (73%) | 13/21 (62%) |
| Time since transplant (years) (median, IQR) | 6.9 (2.5, 8.9) | 3.8 (2.0, 7.7) |
| No. of comorbidities at baseline (median, IQR) | 4.7 (3, 6) | 3.0 (2, 5) |
| TUG >15 seconds at baseline (%) | 6/10 (60%) | 5/20 (25%) |
| Dominant handgrip <10th percentile at baseline (%) | 6/11 (55%) | 9/21 (43%) |
| Median disabled ADLs at baseline (IQR) | 3 (1, 5) | 2 (1, 4) |
| Independent in instrumental ADLs at baseline (%) | 8/11 (73%) | 16/21 (76%) |
| Fall during year of follow-up (%) | 6/11 (55%) | 3/21 (14%) |
| Hospitalized during year of follow-up (%) | 2/11 (18%) | 9/21 (43%) |
Note. ADL = Activities of daily living; IQR = interquartile range; TUG = Timed Up and Go Test.
Figure 2.Changes in functional status in individual BADL and IADL activities.
Note. BADL = basic activities of daily living; IADL = instrumental activities of daily living.